Fig. 2

Identification of tumor antigens associated with GBM prognosis. a Potential tumor antigens (total 1332) with both overexpression and mutation, and tumor antigens significantly associated with OS and RFS (total 9 candidates). Kaplan–Meier curves comparing OS for groups with different expression of ADAMTSL4 (b), COL6A1 (c), CTSL (d), CYTH4 (e), EGFLAM (f), LILRB2 (g), MPZL2 (h), SAA2 (i), and LSP1 (j) in GBM. Red lines represented high gene expression, blue represented low gene expression